Medullary thyroid carcinoma
2 papers
- Human trial1
Latest
1 in 12 monthsPreprints.org
Semaglutide and Papillary Thyroid Carcinoma: Current Evidence on Risk, Progression, and Mechanisms
Preprint: reviewSemaglutide
ENDO 2025 Abstract
SUN-344 Much Ado About Nothing: Tirzepatide and Medullary Thyroid Cancer Debunked
Study in peopleInterventions
Journal of Cellular and Molecular Medicine
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study
Trial in 2 peoplemTOR inhibitors